fbpx

Nobel Ilac

Since over 50 years, NOBEL ILAC San. ve Tic. A.S. is one of the leading pharmaceutical companies in Turkey with successful marketing and sales strategies in the domestic market, supported by a vertical integration of developing and manufacturing pharmaceuticals from scratch. The product portfolio of Nobel comprises self-developed / manufactured pharmaceuticals, prescription pharmaceuticals and OTC products. Nobel is also one of the main exporters of pharmaceuticals in Turkey. With about 2000 employee (of which 850 are medical representatives in the domestic market and 300 in 14 other markets), Nobel is outstanding with its worldwide activities in 15 countries where it has established own subsidiaries and offers to the market thesame service as in Turkey. By 2005, Nobel has been appointed the fastest growing pharmaceutical company in Turkey with a growth rate of 270 %, today positioned in more than 10 prescription ranking. This is due to its flexibility to thechanging market requirements and its dynamism which enables Nobel to set-up new strategies whenever required – an essential property for the dynamic Turkish market andthe developing markets in Central Asia and the Balkan countries. We have been working in Ukraine as representative office of Nobel Ilac since 2005. Our aim is to be one of the leading pharmaceutical companies of Ukraine in the following years as Nobel Turkey achieved. Our sales growth so far proved that we are on the right path to realize our goals. We are committed to be a valued company to patients, customers, colleagues, business partners, and the communities. We will do our best to increase the life quality of the people in Ukraine.

Please note!
Collaboration of companies with shared values is main goal of this project.
We will receive your message and, in two work days, we will redirect it to a company's employee whom it can be as useful as possible.
Your company has 10 opportunities per year to get acquainted with other companies. If you want to increase this amount, please contact us
Please note, that according to EBA Code of Conduct it is prohibited to perform on the EBA platform any coordinated actions, which may limit the competition between the EBA Members.
Write us in case of additional questions and suggestions.

Spelling error report

The following text will be sent to our editors: